- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Meet the New PsychU PTSD Section Advisor: Dr. James Murrough
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Meet the New PsychU PTSD Section Advisor: Dr. James Murrough
During an expert interview, Otsuka Sr. Medical Science Liaison (MSL), Mark Tacelosky, will be talking with the new PsychU Post Traumatic Stress Disorder (PTSD) Section Advisor Dr. James Murrough. The conversation will cover Dr. Murrough’s experience treating PTSD and include his thoughts on challenges, unmet needs, and the future of treatment.
Featuring
James Murrough, M.D., Ph.D.
Associate Professor of Psychiatry and Neuroscience, Director of the Depression & Anxiety Center for Discovery & Treatment, Icahn School of Medicine at Mount Sinai
MoreJames Murrough, M.D., Ph.D., is an Associate Professor of Psychiatry and Neuroscience, and the Director of the Depression & Anxiety Center for Discovery & Treatment at the Icahn School of Medicine at Mount Sinai. He conducts clinical and translational research aimed at understanding the biological basis of mood and anxiety disorders. Dr. Murrough received his medical degree from Tufts University School of Medicine and a doctoral degree from Mount Sinai.James Murrough is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
Mark Tacelosky is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
March 2025 US.CORP.X.25.00042Registration
Related Resources
-
Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)
On-Demand Webinar December 3, 2025In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.
-
Myths & Misconceptions: Bipolar Disorder
Podcast November 10, 2025Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.
-
Understanding the Complexity of Attention-Deficit Hyperactivity Disorder
On-Demand Webinar October 16, 2025Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: